Changes in intestinal microflora following levofloxacin administration in laboratory animals;Modificazioni della flora batterica intestinale a seguito di somministrazione di levofloxacina in animali da laboratorio

Infezioni in Medicina

Volumn 13, Issue 3, 2005, Pages 168-174

  Ianniello, Filomena ^a   Noviello, Silvana ^a   Leone, Sebastiano ^a   Esposito, Silvano ^a   Lucisano, Antonia ^b   Ciarcia, Roberto ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Intestinal microflora; Levofloxacin

Indexed keywords

LEVOFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CANDIDA; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FUNGAL COLONIZATION; GASTROINTESTINAL TRACT; GRAM NEGATIVE BACTERIUM; IMMUNE DEFICIENCY; INTESTINE FLORA; INTESTINE INFECTION; MOUSE; NONHUMAN; URINARY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE AEROBIC BACTERIA; INTESTINES; MICE; MODELS, ANIMAL; OFLOXACIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27744484933     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hawrelak J.A., Myers S.P. The causes of intestinal dysbiosis: a review. Altern. Med. Rev., 9, 2, 180-197, 2004.
2. Stiefel U., Pultz N.J., Helfand M.S., Donskey C.J. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persist after completion of anti-anaerobic antibiotic treatment in mice. Infect. Control Hosp. Epidemiol., 25, 5, 373-379, 2004.
3. Stiefel U., Donskey C.J. The role of the intestinal tract as a source for transmission of nosocomial pathogens. Curr. Infect. Dis. Rep., 6, 6, 420-425, 2004.
4. Nord C.E., Farrell D.J., Leclercq R. Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections. Microb. Drug Resist., 10, 3, 255-263, 2004.
5. Donskey C.J. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis., 39, 2, 219-226, 2004.
6. Edlund C., Nord C.E. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J. Antimicrob. Chemother., 46, Suppl. S1, 41-48, 2000.
7. Edlund C., Nord C.E. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol. J., 3, 137-164, 1993.
8. Vollard E.J., Clasener H.A. Colonization resistance. Antimicrob. Agents Chemother., 38, 409-414, 1994.
9. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science, 264, 375-382, 1994.
10. Salyers A.A., Shoemaker N.B. Resistance gene transfer in anaerobes: new insights, new problems. Clin. Infect. Dis., 23, Suppl. 1, 36-43, 1996.
11. Bertazzoni Minelli E., Benini A. et al. Antibiotics and their interaction with intestinal contents. Microecol. Themp., 25, 360-367, 1995.
12. Nord C.E., Edlund C. Impact of antimicrobial agents on human intestinal microflora. J. Chemother., 2, 218-237, 1990.
13. Carman RJ, Woodburn MA. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora. Regul. Toxicol Pharmacol., 33, 3, 276-284, 2001.
14. Midtvedt T. The influence of quinolones on the faecal flora. Scand. J. Infect Dis. Suppl., 68, 14-18, 1990.
15. Inagaki Y., Nakaya R., Chida T., Hashimoto S. The effect of levofloxacin, an optically-active isomer of ofloxacin, on fecal microflora in human volunteers. Jpn. J. Antibiot., 45, 3, 241-252, 1992.
16. Inagaki Y., Yamamoto N., Chida T., Okamura N., Tanaka M. The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers. Jpn. J. Antibiot., 48, 3, 368-379, 1995.
17. Edlund C., Sjostedt S., Nord C.E. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand. J. Infect. Dis., 29, 4, 383-386, 1997.
18. Appelbaum P.C. Quinolone activity against anaerobes. Drugs, 58, Suppl. 2, 60-64, 1999.
19. th International Congress on Infectious Diseases, Boston, May 1998.
20. Donahue P.E., Smith D.L., Yellin A.B., et al. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin: Tovafloxacin Surgical Group. Am. J. Surg., 176, Suppl 6A, 53S-61S, 1998.
21. Korten V., Murray B.E. Impact of the fluoroquinolones on gastrointestinal flora. Drugs 45, Suppl. 3, 125-133, 1993.
22. National Committee for Clinical Laboratory Standards. 2002 Performance standard for antimicrobial susceptibility testing. Twelfth Informational Supplement M100-S12 Vol. 22 No 1.
23. Vase W., Fiorentino R. Antibiotics effects on intestinal flora: its modifications with the antibiotics used in the clinical practice of gastroenterology. Acta Gastrenterol. Latinoam. 33, 1, 37-41, 2003.
24. Giuliano M., Barza M., Jacobus V., Gorbach S.L. Effect of broad-spectrum antibiotics on composition of intestinal microflora of humans. Antimicrob. Agents Chemother., 31, 202-206, 1987.
25. Donskey C.J., Chowdhry T.K., Hecker M.T., Hoyen C.K., Hanrahan J.A. et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med., 343, 1925-1932, 2000.
26. Horn R., Robson H.G. Susceptibility of the Bacteroides fragilis group to newer quinolones and other tandard anti-anaerobic agents. J. Antimicrob. Chemother., 48, 127-130, 2001.
27. Donskey C.J., Hanrahan J.A., Hutton R.A., Rice L.B. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect. Dis., 180, 384-390, 1999.
28. Ramon J., Ben-Haim M., Shabtai M., Bubenstein E. Transepithelial intestinal excretion of ciprofloxacin in humans. Clin. Infect. Dis., 32, 822-823, 2001.
29. Edlund C., Nord C.E. Effect of quinolones on intestinal ecology. Drugs 58, Suppl. 2, 65-70, 1999.
30. Nord C.E., Gajjar D.A., Grasela D.M. Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora. Clin. Microbiol. Infect., 8, 229-239, 2002.
31. Donskey C.J., Helfand M.S., Pultz N.J., Rice L.B. Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Antimicrob. Agents Chemother., 48, 326-328, 2004.
32. Edlund C., Beyer G., Hiemer-Bau M., Ziege S., Lode H., Nord C.E. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal flora. Scand. J. Infect. Dis., 32, 81-85, 2000.